Lezcano, Cecilia <br/><br/>
Evaluation of stromal HGF immunoreactivity as a biomarker for melanoma response to RAF inhibitors.  [electronic resource] 

 -  Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc  Sep 2014 
 - 1193-202 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1530-0285 
<br/><br/><label>Standard No.: </label>10.1038/modpathol.2013.226  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--therapeutic use<br/>Biomarkers, Tumor--metabolism<br/>Blotting, Western<br/>Cell Line<br/>Fibroblasts--metabolism<br/>Gene Expression<br/>Hepatocyte Growth Factor--metabolism<br/>Humans<br/>Imidazoles--therapeutic use<br/>Immunohistochemistry<br/>Indoles--therapeutic use<br/>Melanoma--drug therapy<br/>Oximes--therapeutic use<br/>Protein Kinase Inhibitors--therapeutic use<br/>Proto-Oncogene Proteins B-raf--antagonists & inhibitors<br/>RNA, Messenger--genetics<br/>Real-Time Polymerase Chain Reaction<br/>Skin--cytology<br/>Skin Neoplasms--drug therapy<br/>Sulfonamides--therapeutic use<br/>Transfection<br/>Vemurafenib